SERPINB13 and type 1 diabetes mellitus: The relevance of studies on serpinB13 in mice to humans was underscored by a finding that children with recent onset T1D and who are positive for serpinB13 AA progress to clinically visible pancreatic β-cell defect at a slower rate compared with T1D patients that are negative for this AA.